Skip to content

Drug interactions

Lomitapide + Simvastatin

Severity: Major

Lomitapide and Simvastatin: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lomitapide is a weak CYP3A4 inhibitor and increases simvastatin exposure. This raises the risk of myopathy, and both drugs can also raise liver enzymes.

What this interaction means in plain words

Lomitapide and Simvastatin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Lomitapide belongs to Cardiovascular; Simvastatin belongs to Cardiovascular.

Evidence level: High

Why it happens

Lomitapide inhibits CYP3A4, reducing simvastatin metabolism.

What to do

Reduce the simvastatin dose by half when starting lomitapide, and do not exceed the labeled maximum simvastatin dose. Monitor for muscle symptoms and liver enzymes.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lomitapide and Simvastatin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lomitapide with Simvastatin?

MediHelp rates the interaction as major. Lomitapide and Simvastatin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Lomitapide is a weak CYP3A4 inhibitor and increases simvastatin exposure. This raises the risk of myopathy, and both drugs can also raise liver enzymes.

How serious is the interaction between Lomitapide and Simvastatin?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce the simvastatin dose by half when starting lomitapide, and do not exceed the labeled maximum simvastatin dose. Monitor for muscle symptoms and liver enzymes.

What other medicines interact with Simvastatin?

MediHelp also lists interactions of Simvastatin with, for example, Atazanavir, Clarithromycin, Cobicistat. The full list is on the Simvastatin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in